For example, in the case of traditional vaccines it depends mainly on the characteristics of the infection that it is wanted to avoid, so, for example, intracellular pathogens may need adjuvants that trigger CD8+ responses, while others that target the intercellular space may need to stimulate innate immunity, B cells and also CD4+ cells. Here, CD8A is linked to infection.